London, October 2025

After of its UK launch, 75Pharma, the impact driven pharmaceutical company is preparing to expand into Finland, the next critical step in its European growth strategy. 75Pharma’s products are competitively priced and designed for conscious consumers who seek both therapeutic effectiveness and the opportunity to support ethical business practices. Its entry into Finland will anchor the brand’s broader Nordic market expansion, bringing a unique value proposition to one of the most forward-thinking healthcare regions in the world.

Nordic Expansion: A Natural Next Step

With established headquarters in Helsinki and Stockholm, 75Pharma is perfectly positioned to bring its impact model to Nordic consumers who value sustainability, transparency, and well-being at the core of their choices.

“Finland and the wider Nordic region share our belief that health and ethics go hand in hand,” said Tessa Koivunen, CEO of 75Pharma. “This expansion is more than a market move, it’s a cultural alignment with communities who expect more from the companies they support. We see the Nordics not just as new markets, but as partners in shaping the future of responsible healthcare.”

Building a growing impact movement in pharma

As part of its broader European growth strategy, 75Pharma is expanding its presence across the Nordics, beginning with the upcoming launch in Finland. The company’s goal is to replicate the success of its UK debut by forming partnerships with trusted retailers and distributors, ensuring its message and products reach conscious consumers throughout the region.

This next phase reinforces 75Pharma’s vision to lead a new era of impact-driven pharmaceuticals, where innovation, ethics, and sustainability define what modern healthcare can, and should be. 75Pharma will release Nordic launch timings separately.

Media & Partner Inquiries

75Pharma welcomes conversations with distributors, investors, healthcare providers, and media representatives as it enters the UK and Nordic markets.

• Sales & Distribution: sales@75pharmagroup.com

• Collaborations & Media Inquiries: pr@75pharmagroup.com

• Investor Relations: investorrelations@75pharmagroup.com

For more information, visit www.75pharmagroup.com

About 75Pharma

75Pharma is an impact company built to create lasting change for people and the planet. With operations in London, Stockholm, and Helsinki, the company offers premium pharmaceutical products designed for conscious consumers who seek both therapeutic effectiveness and the opportunity to support ethical business practices. Its launch in the UK marks a significant step toward building a more responsible and sustainable pharmaceutical future, with further expansion as a first step into the Nordics planned as part of its broader European growth strategy.

75Pharma – A way to feel better